4//SEC Filing
Litchman Manuel MD 4
Accession 0001104659-23-040934
CIK 0001680048other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:51 PM ET
Size
16.9 KB
Accession
0001104659-23-040934
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2022-06-21+61,000→ 1,093,987 total - Purchase
COMMON STOCK, PAR VALUE $0.0001
2022-09-13$0.52/sh+5,000$2,582→ 1,098,987 total - Purchase
COMMON STOCK, PAR VALUE $0.0001
2022-03-18$0.74/sh+5,000$3,695→ 1,032,987 total
Footnotes (3)
- [F1]Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
- [F2]Includes restricted share units, which vest over various time periods.
- [F3]Represents an award of 61,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2026.
Issuer
MUSTANG BIO, INC.
CIK 0001680048
Entity typeother
Related Parties
1- filerCIK 0001709485
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:51 PM ET
- Size
- 16.9 KB